Position Statements

Guidelines

Here you will find our prescribing guidelines including shared care guidelines and patient information leaflets.

To see which CCGs have adopted the guidance please download the document below:

Name	Size	Hits
Biological Agents For Treating JIA In Adult Patients (Version 2.0)	208.7 KiB	861
Biosimilars of Etanercept (Version 1.0)	268.5 KiB	645
Biosimilars of Infliximab (Version 1.1)	271.7 KiB	1926
Camouflage Products Position Statement (Version 1.1)	166.3 KiB	50
Cannabis Based Medicinal Products For Pain (Version 1.0)	464.8 KiB	350
Choice of direct-acting oral anticoagulant (DOAC) for stroke prevention in atrial fibrillation (AF) (Version 1.2)	213.3 KiB	682
Denosumab Position Statement (Version 1.0)	291.3 KiB	733
E‑Cigarettes Position Statement (Version 2.0)	162.8 KiB	975
Empagliflozin Position Statement (Version 1.0)	577.8 KiB	1207
Fentanyl & Buprenorphine Patches For Pain (Version 1.0)	332.4 KiB	48767
Generic Biosimilar Position Statement (Version 1.0)	218.0 KiB	778
Melatonin Position Statement (Version 1.2)	615.1 KiB	962
Nutritional Supplements Post Bariatric Surgery (version 1.1)	281.4 KiB	7571
Out Of Area Prescribing Position Statement (Version 1.0)	166.1 KiB	198
PKU (Phlexy-Vit) Position Statement (Version 1.0)	664.8 KiB	433
Trans-Anal Irrigation Devices Position Statement (version 1.2)	230.4 KiB	1839
Vitamin D Position Statement (Version 3.0)	195.7 KiB	4170
Vitamins And Minerals (Version 1.2)	295.0 KiB	1510